The performance of cerebrospinal fluid treponemal-specific antibody tests in neurosyphilis: A systematic review

Sexually Transmitted Diseases

Volumn 39, Issue 4, 2012, Pages 291-297

  Harding, Alexander S ^a   Ghanem, Khalil G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHASIA; ARTICLE; ATAXIA; BIBLIOGRAPHIC DATABASE; BLADDER DYSFUNCTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL PRACTICE; COCHRANE LIBRARY; CRANIAL NERVE PARALYSIS; DATA ANALYSIS; DATA BASE; DEMENTIA; DISEASE REGISTRY; ENZYME IMMUNOASSAY; FLUORESCENT TREPONEMA ANTIBODY TEST; HEMIPARESIS; HEMIPLEGIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYDROCEPHALUS; MEDICAL LITERATURE; MEDLINE; MENINGISM; MYELITIS; NEUROSYPHILIS; OPTIC NERVE ATROPHY; PAIN; PARESTHESIA; PERCEPTION DEAFNESS; PERSONALITY DISORDER; PLEOCYTOSIS; PREDICTIVE VALUE; PROBABILITY; PROTEIN CEREBROSPINAL FLUID LEVEL; PUPIL DISEASE; QUALITY CONTROL; SEIZURE; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

ANTIBODIES, BACTERIAL; FEMALE; FLUORESCENT TREPONEMAL ANTIBODY-ABSORPTION TEST; HUMANS; MALE; NEUROSYPHILIS; PREDICTIVE VALUE OF TESTS; SYPHILIS SERODIAGNOSIS; TREPONEMA PALLIDUM;

EID: 84858706755     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31824c0e62     Document Type: Article

References (27)

1. Lukehart SA, Hook EW III, Baker-Zander SA, et al. Invasion of the central nervous system by Treponema pallidum: Implications for diagnosis and treatment. Ann Intern Med 1988; 109:855-862. (Pubitemid 19000024)
2. Hart G. Syphilis tests in diagnostic and therapeutic decisionmaking. Ann Intern Med 1986; 104:368-376. (Pubitemid 16163620)
3. Workowski KA, Berman S. Centers for Disease Control and Prevention (CDC). Sexual Transmitted Disease Treatment Guidelines, 2010. MMWR Recomm Rep 2010; 59:1-110.
4. Kaplan JE, Benson C, Holmes KH, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58:1, 207; quiz CE1-4.
5. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17:1-12. (Pubitemid 26120810)
6. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med 2009; 6:e1000100.
7. Escobar MR, Dalton HP, Allison MJ. Fluorescent antibody tests for syphilis using cerebrospinal fluid: Clinical correlation in 150 cases. Am J Clin Pathol 1970; 53:886-890.
8. Mahony JD, Harris JR, McCann JS, et al. Evaluation of the C.S.F. FTA ABS test in latent and tertiary treated syphilis. Acta Derm Venereol 1972; 52:71-74.
9. Duncan WP, Jenkins TW, Parham CE. Fluorescent treponemal antibody-cerebrospinal fluid (FTA-CSF) test. A provisional technique. Br J Vener Dis 1972; 48:97-101.
10. Hooshman H, Escobar MR, Kopf SW. Neurosyphilis-A study of 241 patients. JAMA 1972; 219:726-729.
11. Wilkinson AE. Fluorescent treponemal antibody tests on cerebrospinal fluid. Br J Vener Dis 1973; 49:346-349.
12. Jaffe HW, Larsen SA, Peters M, et al. Tests for treponemal antibody in CSF. Arch Intern Med 1978; 138:252-255. (Pubitemid 9039635)
13. Mcgeeney T, Yount F, Hinthorn DR, et al. Utility of the FTAABS test of cerebrospinal-fluid in the diagnosis of neurosyphilis. Sex Transm Dis 1979; 6:195-198.
14. Birry A, Kasatiya S. Evaluation of microhaemagglutination assay to determine treponemal antibodies in CSF. Br J Vener Dis 1979; 55:239-244. (Pubitemid 9254949)
15. Kasatiya S, Birry A. Further evaluation of the microhaemagglutination test to determine treponemal antibodies in CSF. Br J Vener Dis 1980; 56:77-80. (Pubitemid 10094548)
16. Luger A, Schmidt BL, Steyrer K, et al. Diagnosis of neurosyphilis by examination of the cerebrospinal fluid. Br J Vener Dis 1981; 57:232-237. (Pubitemid 11062165)
17. van Eijk RV, Wolters EC, Tutuarima JA, et al. Effect of early and late syphilis on central nervous system: Cerebrospinal fluid changes and neurological deficit. Genitourin Med 1987; 63:77-82. (Pubitemid 17047263)
18. Smikle MF, James OB, Prabhakar P. Diagnosis of neurosyphilis: A critical assessment of current methods. South Med J 1988; 81:452-454.
19. Lee CT, Cheong WK, Thirumoorthy T, et al. Evaluation of cerebrospinal fluid in asymptomatic late syphilis. Ann Acad Med Singapore 1989; 18:684-686.
20. Marra CM, Critchlow CW, Hook EW III, et al. Cerebrospinal fluid treponemal antibodies in untreated early syphilis. Arch Neurol 1995;52:68-72.
21. Luger AF, Schmidt BL, Kaulich M. Significance of laboratory findings for the diagnosis of neurosyphilis. Int J STD AIDS 2000; 11:224-234. (Pubitemid 30171196)
22. Marra CM, Tantalo LC, Maxwell CL, et al. Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals. Neurology 2004; 63:85-88. (Pubitemid 38943783)
23. Castro R, Prieto ES, Aguas MJ, et al. Evaluation of the Treponema pallidum particle agglutination technique (TP.PA) in the diagnosis of neurosyphilis. J Clin Lab Anal 2006; 20:233-238. (Pubitemid 44865235)
24. Izzat NN, Bartruff JK, Glicksman JM, et al. Validity of the VDRL test on cerebrospinal fluid contaminated by blood. Br J Vener Dis 1971; 47:162-164.
25. Davis LE, Sperry S. The CSF-FTA test and the significance of blood contamination. Ann Neurol 1979; 6:68-69. (Pubitemid 9188037)
26. O'Donnell JA, Emery CL. Neurosyphilis: A current review. Curr Infect Dis Rep 2005; 7:277-284. (Pubitemid 41149700)
27. Marra CM, Tantalo LC, Sahi SK, et al. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis. Sex Transm Dis 2010; 37:283-287.